Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at cisplatin, gemcitabine and temsirolimus to treat cancer that has spread (ToTem)

Overview

Cancer types:

Bladder cancer, Kidney cancer, Transitional cell cancer

Status:

Closed

Phase:

Phase 1/2

Details

This trial is looking at how well a drug called temsirolimus (Torisel) works with cisplatin and gemcitabine chemotherapy to treat cancer that has spread into surrounding tissue (locally advanced), or to another part of the body.

Cancer Research UK supports this trial.

Recruitment start: 31 December 2012

Recruitment end: 15 March 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr John Chester

Supported by

Cancer Research UK

Cardiff University

Experimental Cancer Medicine Centre (ECMC)

Pfizer

Wales Clinical Trials Unit (WCTU)

Other information

This is Cancer Research UK trial number is CRUK/08/015.

Last reviewed: 18 September 2016

CRUK internal database number: 145

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.